Kwiatkowski JL, Thompson AA, Tricta F, Temin NT, et al. Real-world evidence: Long-term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years. Am J Hematol 2024;99:1031-1039.
PMID: 38429922